These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9333262)

  • 1. Prescribing protease inhibitors for the homeless.
    Lyman A
    JAMA; 1997 Oct; 278(15):1235-6. PubMed ID: 9333262
    [No Abstract]   [Full Text] [Related]  

  • 2. Protease inhibitors in the homeless.
    Bangsberg D; Tulsky JP; Hecht FM; Moss AR
    JAMA; 1997 Jul; 278(1):63-5. PubMed ID: 9207341
    [No Abstract]   [Full Text] [Related]  

  • 3. San Francisco General Hospital: studies for patients beginning antiretroviral treatment.
    AIDS Treat News; 1999 Aug; (No 325):7-8. PubMed ID: 11366576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tipranavir (Aptivus) for HIV.
    Med Lett Drugs Ther; 2005 Oct; 47(1219):83-4. PubMed ID: 16247341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population.
    Bangsberg DR; Hecht FM; Charlebois ED; Zolopa AR; Holodniy M; Sheiner L; Bamberger JD; Chesney MA; Moss A
    AIDS; 2000 Mar; 14(4):357-66. PubMed ID: 10770537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV-1 protease inhibitors. Why, when, and how?].
    Gatell JM
    Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):393-4. PubMed ID: 9887623
    [No Abstract]   [Full Text] [Related]  

  • 7. [Virologic levels for HIV before and after the introduction of protease inhibitors].
    Molinero M; Solano C; Gomez-Cano M; Soriano V
    An Med Interna; 1998 Sep; 15(9):508-9. PubMed ID: 10079548
    [No Abstract]   [Full Text] [Related]  

  • 8. Dual therapy with lamivudine + protease inhibitor during pregnancy for prevention of mother-to-child transmission of HIV-1.
    Gliga SS; Clavel CO; Alix AF; Dommergues M; Quetin F; Marcelin AG; Schneider L; Stitou H; Calin R; Caby F; Valantin MA; Katlama C; Tubiana R
    J Acquir Immune Defic Syndr; 2013 Aug; 63(5):e159-63. PubMed ID: 24135778
    [No Abstract]   [Full Text] [Related]  

  • 9. HIV-proteinase inhibitors in the management of HIV-infection.
    Moyle GJ; Barton SE
    J Antimicrob Chemother; 1996 Dec; 38(6):921-5. PubMed ID: 9023639
    [No Abstract]   [Full Text] [Related]  

  • 10. [HIV protease inhibitors].
    Rubio R; Romeu J; Viciana P; Redondo C
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():10-4. PubMed ID: 9053020
    [No Abstract]   [Full Text] [Related]  

  • 11. Significance of P-glycoprotein for the pharmacology and clinical use of HIV protease inhibitors.
    Clayette P; Jorajuria S; Dormont D
    AIDS; 2000 Feb; 14(3):235-6. PubMed ID: 10716498
    [No Abstract]   [Full Text] [Related]  

  • 12. Simple pill box organizers improve HIV adherence. Pill boxes work for marginally housed, homeless.
    AIDS Alert; 2007 Aug; 22(8):90. PubMed ID: 17763557
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver fibrosis in HIV/hepatitis C coinfection: HIV protease inhibitors may be protective.
    James JS
    AIDS Treat News; 2001 Aug; (370):2-3. PubMed ID: 11570162
    [No Abstract]   [Full Text] [Related]  

  • 14. [HIV protease inhibitors. A new drug class in antiretroviral therapy].
    Mauss S; Seidlitz B; Jablonowski H; Häussinger D
    Dtsch Med Wochenschr; 1996 Nov; 121(44):1369-74. PubMed ID: 8964223
    [No Abstract]   [Full Text] [Related]  

  • 15. Paediatric AIDS--is now not the right time to act?
    Matchaba PT; Chapanduka ZC
    S Afr Med J; 1997 Oct; 87(10):1343-5. PubMed ID: 9472245
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress in HIV-1 therapy continues on upward track.
    Montaner J; Mellors J
    Lancet; 1999 Feb; 353(9152):565. PubMed ID: 10028996
    [No Abstract]   [Full Text] [Related]  

  • 17. Switching meds: from protease inhibitors to non-nukes.
    TreatmentUpdate; 2001; 12(10):1-2. PubMed ID: 11570061
    [No Abstract]   [Full Text] [Related]  

  • 18. Homeless HIV program uses creativity, myriad of approaches to improve adherence. Program even has staff at race track.
    AIDS Alert; 2006 Jan; 21(1):7-9. PubMed ID: 16470942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease inhibitors: resistance, cross-resistance, fitness and the choice of initial and salvage therapies.
    Erickson JW; Gulnik SV; Markowitz M
    AIDS; 1999; 13 Suppl A():S189-204. PubMed ID: 10885776
    [No Abstract]   [Full Text] [Related]  

  • 20. The changing face of pediatric HIV-1 infection.
    Sullivan JL; Luzuriaga K
    N Engl J Med; 2001 Nov; 345(21):1568-9. PubMed ID: 11794226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.